HEADLINE EARNINGS   REVENUE GROWTH   DIVIDEND
42% Arrow
 
10% Arrow
 
20% Arrow
Highlights   Highlights   Highlights

INTRODUCTION

The Board of Directors has pleasure in presenting the Group’s audited results for the year ended 30 June 2014.

The publication of AfroCentric’s results for the year ended June 30, 2014 coincides with the announcement of two important strategic initiatives for AfroCentric which are briefly explained herein under “Recent Developments”.

an agreement to acquire WAD Holdings Proprietary Limited (“WAD”) businesses that specialise in wholesaling, dispensing and delivery of chronic medication; and
an agreement for a significant minority investment by Sanlam Limited.

Apart from the satisfactory results of the Group’s business operations, the year ended 30 June 2014 has important significance in the Group’s history. During the year, the AfroCentric Health Limited’s (formerly Lethimvula) profit warranty was finally measured, which triggered the issue of the shares due under the second tranche payment provisions. In addition, ordinary shares were issued to Preference Shareholders in terms of the Preference Share Redemption covenants. Shareholders should consider these factors for a better appreciation of this results announcement.

read more

 

Financials

arrow CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
arrow CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
arrow CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
arrow EARNINGS ATTRIBUTABLE TO EQUITY HOLDERS
arrow CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
arrow SEGMENTAL ANALYSIS

Downloads

Booklet (PDF - 627KB)

 

 

View spreadsheets